Modulation of Amphetamine-Induced Dopamine Release by Group II Metabotropic Glutamate Receptor Agonist LY354740 in Non-Human Primates Studied with Positron Emission Tomography-Reference-Cited by-同舟云学术

Modulation of Amphetamine-Induced Dopamine Release by Group II Metabotropic Glutamate Receptor Agonist LY354740 in Non-Human Primates Studied with Positron Emission Tomography

Published:2005-09-21 Issue:5 Volume:31 Page:967-977
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol

Author:

van Berckel Bart N M,Kegeles Lawrence S,Waterhouse Rikki,Guo Ningning,Hwang Dah-Ren,Huang Yiyun,Narendran Rajesh,Van Heertum Ronald,Laruelle Marc

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/1300902.pdf

Reference66 articles.

1. Aalto S, Hirvonen J, Kajander J, Scheinin H, Nagren K, Vilkman H et al (2002). Ketamine does not decrease striatal dopamine D2 receptor binding in man. Psychopharmacology (Berlin) 164: 401.

2. Abi-Dargham A, Gil R, Krystal J, Baldwin R, Seibyl J, Bowers M et al (1998). Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 155: 761–767.

3. Adams BW, Bradberry CW, Moghaddam B (2002). NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys. Synapse 43: 12–18.

4. Battaglia G, Monn JA, Schoepp DD (1997). In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats. Neurosci Lett 229: 161.

5. Breier A, Adler CM, Weisenfeld N, Su TP, Elman I, Picken L et al (1998). Effects of NMDA antagonism on striatal dopamine release in healthy subjects: application of a novel PET approach. Synapse 29: 142–147.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal Models for Brain Research;PET and SPECT of Neurobiological Systems;2020-09-30

2. Metabotropic Glutamate Receptor 2 and Dopamine Receptor 2 Gene Expression Predict Sensorimotor Gating Response in the Genetically Heterogeneous NIH-HS Rat Strain;Molecular Neurobiology;2019-11-28

3. The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities;Neuroscience & Biobehavioral Reviews;2018-04

4. Neurosurgery for schizophrenia: an update on pathophysiology and a novel therapeutic target;Journal of Neurosurgery;2016-04

5. When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic Efficacy;Current Pharmaceutical Design;2015-08-27